Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Condition: Mesotheliomas Pleural Interventions: Drug: Pembrolizumab; Procedure: Indocyanine Green (ICG) Image-Guided Surgery; Drug: Cisplatin; Drug: Pemetrexed Sponsor: Abramson Cancer Center of the University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Mesothelioma | University of Pennsylvania